Why Georgia


TOP REASONS TO CONDUCT YOUR CLINICAL TRIALS IN GEORGIA

  Lightning fast approval process. Georgia’s regulatory approval process takes on average about two months.

   Georgia’s rapidly growing study-related workforce is well experienced in international, ICH GCP-compliant clinical trials.

  Georgia’s investment in the healthcare sector over the last decade has increased the number of medical facilities and in-patient beds.

   Most hospitals are well-equipped with staff eager to participate in clinical research.

   Investigators and their patients are highly motivated to participate in trials as a way of accessing novel therapies not yet available through the national health          system.

   Good recruitment potential due to an ethnically diverse population with treatmentnaive patients in a broad range of therapeutic areas.

  The cost of conducting clinical research is much lower when compared to the US or Western Europe.

   Economic and political reforms have made Georgia an attractive and welcoming destination for international companies seeking to do business there.

Data for Medical Devices projects done in the third country are acceptable to EU. 


 Healthcare providers are working under highest standard, every medical care provider in Georgia functions under control of the Ministry of Labor, Health and Social Affairs.

 https://www.moh.gov.ge